- Alvarez de la Campa E, Padilla N & de la Cruz X 2017, 'Development of pathogenicity predictors specific for variants that do not comply with clinical guidelines for the use of computational evidence', Bmc Genomics, 18, 569.
- Asensio-Juan E, Fueyo R, Pappa S, Iacobucci S, Badosa C, Lois S, Balada M, Bosch-Presegue L, Vaquero A, Gutierrez S, Caelles C, Gallego C, de la Cruz X & Martinez-Balbas MA 2017, 'The histone demethylase PHF8 is a molecular safeguard of the IFN gamma response', Nucleic Acids Research, 45, 7, 3800 - 3811.
- López-Ferrando V, Gazzo A, de la Cruz X, Orozco M & Gelpí JL 2017, 'PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update', Nucleic Acids Res, vol 45, Web Server Issue, pp W222-W228.
- Vargas-Parra GM, Gonzalez-Acosta M, Thompson BA, Gomez C, Fernandez A, Damaso E, Pons T, Morak M, del Valle J, Iglesias S, Velasco A, Solanes A, Sanjuan X, Padilla N, de la Cruz X, Valencia A, Holinski-Feder E, Brunet J, Feliubadalo L, Lazaro C, Navarro M, Pineda M & Capella G 2017, 'Elucidating the molecular basis of MSH2-deficienttumors by combined germline and somatic analysis', International Journal Of Cancer, 141, 7, 1365 - 1380.
- Franco-Jarava C, Alvarez de la Campa E, Solanich X, Morandeira-Rego F, Mas-Bosch V, Garcia-Prat M, de la Cruz X, Martin-Nalda A, Soler-Palacin P, Hernandez-Gonzalez M & Colobran R 2017, 'Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations', Journal Of Clinical Immunology, 37, 8, 781 - 789.